These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15068858)

  • 1. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice.
    Chattergoon MA; Saulino V; Shames JP; Stein J; Montaner LJ; Weiner DB
    Vaccine; 2004 Apr; 22(13-14):1744-50. PubMed ID: 15068858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
    Li W; Li S; Hu Y; Tang B; Cui L; He W
    Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.
    Otero M; Calarota SA; Felber B; Laddy D; Pavlakis G; Boyer JD; Weiner DB
    Vaccine; 2004 Apr; 22(13-14):1782-90. PubMed ID: 15068862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
    Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
    J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
    Marshall DJ; Rudnick KA; McCarthy SG; Mateo LR; Harris MC; McCauley C; Snyder LA
    Vaccine; 2006 Jan; 24(3):244-53. PubMed ID: 16135392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL.
    Silla S; Fallarino F; Boon T; Uyttenhove C
    Eur Cytokine Netw; 1999 Jun; 10(2):181-90. PubMed ID: 10400824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-18 enhances protective effect in mice immunized with a Schistosoma japonicum FABP DNA vaccine.
    Wei F; Liu Q; Zhai Y; Fu Z; Liu W; Shang L; Men J; Gao S; Lian H; Jin H; Chen C; Lin J; Shi Y; Xia Z; Zhu XQ
    Acta Trop; 2009 Sep; 111(3):284-8. PubMed ID: 19467215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity.
    Toka FN; Rouse BT
    J Leukoc Biol; 2005 Jul; 78(1):178-86. PubMed ID: 15817700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus.
    Langlade-Demoyen P; Garcia-Pons F; Castiglioni P; Garcia Z; Cardinaud S; Xiong S; Gerloni M; Zanetti M
    Eur J Immunol; 2003 Mar; 33(3):720-8. PubMed ID: 12616492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune response induced by HIV DNA vaccine combined with recombinant adeno-associated virus].
    Liu YZ; Zhou L; Wang Q; Ye SQ; Li HX; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):251-4. PubMed ID: 15640860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.